Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein.
The spike protein receptor-binding domain (RBD) of SARS-CoV-2 is the molecular target for many vaccines and antibody-based prophylactics aimed at bringing COVID-19 under control. Such a narrow molecular focus raises the specter of viral immune evasion as a potential failure mode for these biomedical...
שמור ב:
| Principais autores: | , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Public Library of Science (PLoS)
2021-01-01
|
| סדרה: | PLoS ONE |
| גישה מקוונת: | https://doi.org/10.1371/journal.pone.0250780 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
